Literature DB >> 2050939

Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers.

S H Hohnloser1, M Zabel, W Kasper, T Meinertz, H Just.   

Abstract

The predictability of patency of the infarct-related artery assessed by means of three noninvasive easily obtainable markers was prospectively examined in 82 patients undergoing thrombolysis for their first myocardial infarction. Positive noninvasive markers were defined as follows: 1) early peak creatine kinase (CK) activity less than or equal to 12 h after the start of thrombolysis; 2) greater than or equal to 50% reduction in ST segment elevation; and 3) occurrence of reperfusion arrhythmias within the 1st 90 min of thrombolytic therapy. In 63 (77%) of the 82 patients, Thrombolysis in Myocardial Infarction (TIMI) grade II/III reperfusion was achieved within the 1st 90 min as assessed by coronary angiography. Separate analysis of each marker revealed the following respective values for sensitivity, specificity and positive and negative predictive value regarding prediction of coronary artery patency: CK peak less than or equal to 12 h: 84%, 95%, 98% and 64%; reduction of the ST segment elevation greater than or equal to 50%: 60%, 95%, 97% and 42%; and reperfusion arrhythmias: 63%, 89%, 95% and 43%. The combined analysis of all three markers utilizing a logistic regression procedure showed that CK peak (p = 0.0001) and resolution of the ST segment elevation (p = 0.005), but not the occurrence of reperfusion arrhythmias (p = 0.26), were independent predictors of vessel patency. From this logistic regression procedure, a sensitivity of 100%, a specificity of 90%, a positive predictive value of 97% and a negative predictive value of 100% for prediction of coronary artery patency were obtained.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050939     DOI: 10.1016/s0735-1097(10)80215-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

Review 1.  The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction.

Authors:  M Vaturi; Y Birnbaum
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

2.  The Open-Artery Hypothesis: An Overview.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

3.  Early, Complete Infarct Vessel Patency: Arriving at a Gold Standard for Future Clinical Investigation in Myocardial Reperfusion.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

4.  Evaluation of coronary artery patency using cardiac markers.

Authors:  Milenko J Tanasijevic
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

Review 5.  Streptokinase--the drug of choice for thrombolytic therapy.

Authors:  Adinarayana Kunamneni; Thaer Taleb Abed Abdelghani; Poluri Ellaiah
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

Review 6.  [Enzymatic markers of reperfusion in acute myocardial infarct. With data from the ISAM study].

Authors:  S Walter; J Carlsson; R Schröder; K L Neuhaus; E Sorges; U Tebbe
Journal:  Herz       Date:  1999-10       Impact factor: 1.443

7.  Usefulness of reperfusion ventricular arrhythmias in non-invasive prediction of early reperfusion and sustained coronary artery patency in acute myocardial infarction.

Authors:  J A Chiladakis; N Vlachos; N Patsouras; A Mazarakis; A S Manolis
Journal:  J Thromb Thrombolysis       Date:  2001-12       Impact factor: 2.300

8.  Contribution of Electrocardiographic Accelerated Ventricular Rhythm Alarms to Alarm Fatigue.

Authors:  Sukardi Suba; Cass Piper Sandoval; Jessica K Zègre-Hemsey; Xiao Hu; Michele M Pelter
Journal:  Am J Crit Care       Date:  2019-05       Impact factor: 2.228

9.  Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytes.

Authors:  R J de Winter; A Manten; Y P de Jong; R Adams; S J van Deventer; K I Lie
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

10.  Efficacy and safety of a new streptokinase regimen with enoxaparin in acute myocardial infarction.

Authors:  Gabriel Tatu-Chitoiu; Cristina Teodorescu; Monica Dan; Petre Capraru; Manuela Guran; Oana Istratescu; Alexandrina Tatu-Chitoiu; Aurelia Bumbu; Maria Dorobantu
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.